Author: Diksha Patil Introduction: Dr. Reddy’s Laboratories is a leading Indian multinational pharmaceutical company. In finance, evaluating a stock’s performance relative to a market benchmark (like the NIFTY 50) is essential for understanding its risk-return profile. This analysis uses the Capital Asset Pricing Model (CAPM) framework to determine the stock’s systematic risk, commonly known as… Continue reading Relationship of Nifty 50 with Dr. Reddy’s Laboratories Limited